 | • レポートコード：MRC2012A6409 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニロチニブの世界市場を広く調査・分析し、今後の市場展望をまとめております。ニロチニブの種類別市場規模（50mg、200mg、その他）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、 ・地域別グローバル市場分析 2015年-2020年 ・ニロチニブの北米市場（アメリカ、カナダ、メキシコ） ・ニロチニブのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニロチニブのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニロチニブの南米市場（ブラジル、アルゼンチン） ・ニロチニブの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：50mg、200mg、その他 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nilotinib market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nilotinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nilotinib market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nilotinib market has been segmented into
50mg
200mg
Other
By Application, Nilotinib has been segmented into:
Hospital
Drugs Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nilotinib market presented in the report. This section sheds light on the sales growth of different regional and country-level Nilotinib markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nilotinib market.
The report offers in-depth assessment of the growth and other aspects of the Nilotinib market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nilotinib Market Share Analysis
Nilotinib competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nilotinib sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nilotinib sales, revenue and market share for each player covered in this report.
The major players covered in Nilotinib are:
Novartis
Among other players domestic and global, Nilotinib market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nilotinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nilotinib, with price, sales, revenue and global market share of Nilotinib in 2018 and 2019.
Chapter 3, the Nilotinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nilotinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nilotinib market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nilotinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nilotinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nilotinib Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nilotinib Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Overview of Global Nilotinib Market
1.4.1 Global Nilotinib Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Nilotinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nilotinib Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nilotinib Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nilotinib Manufacturer Market Share in 2019
3.3.2 Top 6 Nilotinib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nilotinib Sales, Revenue and Market Share by Regions
4.1.1 Global Nilotinib Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nilotinib Revenue and Market Share by Regions (2015-2020)
4.2 North America Nilotinib Sales and Growth Rate (2015-2020)
4.3 Europe Nilotinib Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nilotinib Sales and Growth Rate (2015-2020)
4.5 South America Nilotinib Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nilotinib Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nilotinib Sales, Revenue and Market Share by Country
5.1.1 North America Nilotinib Sales and Market Share by Country (2015-2020)
5.1.2 North America Nilotinib Revenue and Market Share by Country (2015-2020)
5.2 United States Nilotinib Sales and Growth Rate (2015-2020)
5.3 Canada Nilotinib Sales and Growth Rate (2015-2020)
5.4 Mexico Nilotinib Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nilotinib Sales, Revenue and Market Share by Country
6.1.1 Europe Nilotinib Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nilotinib Revenue and Market Share by Country (2015-2020)
6.2 Germany Nilotinib Sales and Growth Rate (2015-2020)
6.3 UK Nilotinib Sales and Growth Rate (2015-2020)
6.4 France Nilotinib Sales and Growth Rate (2015-2020)
6.5 Russia Nilotinib Sales and Growth Rate (2015-2020)
6.6 Italy Nilotinib Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nilotinib Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nilotinib Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nilotinib Revenue and Market Share by Regions (2015-2020)
7.2 China Nilotinib Sales and Growth Rate (2015-2020)
7.3 Japan Nilotinib Sales and Growth Rate (2015-2020)
7.4 Korea Nilotinib Sales and Growth Rate (2015-2020)
7.5 India Nilotinib Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nilotinib Sales and Growth Rate (2015-2020)
7.7 Australia Nilotinib Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nilotinib Sales, Revenue and Market Share by Country
8.1.1 South America Nilotinib Sales and Market Share by Country (2015-2020)
8.1.2 South America Nilotinib Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nilotinib Sales and Growth Rate (2015-2020)
8.3 Argentina Nilotinib Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nilotinib Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nilotinib Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nilotinib Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nilotinib Sales and Growth Rate (2015-2020)
9.3 Turkey Nilotinib Sales and Growth Rate (2015-2020)
9.4 Egypt Nilotinib Sales and Growth Rate (2015-2020)
9.5 South Africa Nilotinib Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nilotinib Sales and Market Share by Type (2015-2020)
10.2 Global Nilotinib Revenue and Market Share by Type (2015-2020)
10.3 Global Nilotinib Price by Type (2015-2020)
11 Global Nilotinib Market Segment by Application
11.1 Global Nilotinib Sales Market Share by Application (2015-2020)
11.2 Global Nilotinib Revenue Market Share by Application (2015-2020)
11.3 Global Nilotinib Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nilotinib Sales, Revenue and Growth Rate (2021-2025)
12.2 Nilotinib Market Forecast by Regions (2021-2025)
12.2.1 North America Nilotinib Market Forecast (2021-2025)
12.2.2 Europe Nilotinib Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nilotinib Market Forecast (2021-2025)
12.2.4 South America Nilotinib Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nilotinib Market Forecast (2021-2025)
12.3 Nilotinib Market Forecast by Type (2021-2025)
12.3.1 Global Nilotinib Sales Forecast by Type (2021-2025)
12.3.2 Global Nilotinib Market Share Forecast by Type (2021-2025)
12.4 Nilotinib Market Forecast by Application (2021-2025)
12.4.1 Global Nilotinib Sales Forecast by Application (2021-2025)
12.4.2 Global Nilotinib Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nilotinib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nilotinib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nilotinib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Nilotinib Major Business
Table 9. Novartis Nilotinib Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Nilotinib Product and Services
Table 12. Novartis Nilotinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Nilotinib Sales by Manufacturer (2018-2019) (MT)
Table 14. Global Nilotinib Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Nilotinib Sales by Regions (2015-2020) (MT)
Table 16. Global Nilotinib Sales Market Share by Regions (2015-2020)
Table 17. Global Nilotinib Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Nilotinib Sales by Countries (2015-2020) (MT)
Table 19. North America Nilotinib Sales Market Share by Countries (2015-2020)
Table 20. North America Nilotinib Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Nilotinib Revenue Market Share by Countries (2015-2020)
Table 22. Europe Nilotinib Sales by Countries (2015-2020) (MT)
Table 23. Europe Nilotinib Sales Market Share by Countries (2015-2020)
Table 24. Europe Nilotinib Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Nilotinib Sales by Regions (2015-2020) (MT)
Table 26. Asia-Pacific Nilotinib Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Nilotinib Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Nilotinib Sales by Countries (2015-2020) (MT)
Table 29. South America Nilotinib Sales Market Share by Countries (2015-2020)
Table 30. South America Nilotinib Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Nilotinib Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Nilotinib Sales by Countries (2015-2020) (MT)
Table 33. Middle East & Africa Nilotinib Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Nilotinib Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Nilotinib Revenue Market Share by Countries (2015-2020)
Table 36. Global Nilotinib Sales by Type (2015-2020) (MT)
Table 37. Global Nilotinib Sales Share by Type (2015-2020)
Table 38. Global Nilotinib Revenue by Type (2015-2020) (USD Million)
Table 39. Global Nilotinib Revenue Share by Type (2015-2020)
Table 40. Global Nilotinib Sales by Application (2015-2020) (MT)
Table 41. Global Nilotinib Sales Share by Application (2015-2020)
Table 42. Global Nilotinib Sales Forecast by Regions (2021-2025) (MT)
Table 43. Global Nilotinib Market Share Forecast by Regions (2021-2025)
Table 44. Global Nilotinib Sales Forecast by Type (2021-2025) (MT)
Table 45. Global Nilotinib Market Share Forecast by Type (2021-2025)
Table 46. Global Nilotinib Sales Forecast by Application (2021-2025)
Table 47. Global Nilotinib Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nilotinib Picture
Figure 2. Global Sales Market Share of Nilotinib by Type in 2019
Figure 3. 50mg Picture
Figure 4. 200mg Picture
Figure 5. Other Picture
Figure 6. Nilotinib Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drugs Store Picture
Figure 9. Other Picture
Figure 10. Global Nilotinib Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Nilotinib Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Nilotinib Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Nilotinib Sales Market Share by Manufacturer in 2019
Figure 31. Global Nilotinib Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Nilotinib Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Nilotinib Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Nilotinib Revenue Market Share by Regions (2015-2020)
Figure 38. Global Nilotinib Revenue Market Share by Regions in 2018
Figure 39. North America Nilotinib Sales and Growth Rate (2015-2020)
Figure 40. Europe Nilotinib Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Nilotinib Sales and Growth Rate (2015-2020)
Figure 42. South America Nilotinib Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Nilotinib Sales and Growth Rate (2015-2020)
Figure 44. North America Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Nilotinib Sales Market Share by Countries (2015-2020)
Figure 46. North America Nilotinib Sales Market Share by Countries in 2018
Figure 47. North America Nilotinib Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Nilotinib Revenue Market Share by Countries in 2018
Figure 49. United States Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Nilotinib Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Nilotinib Revenue Market Share by Countries in 2019
Figure 55. Germany Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Nilotinib Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Nilotinib Revenue Market Share by Regions 2019
Figure 63. China Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Nilotinib Sales Market Share by Countries in 2019
Figure 70. South America Nilotinib Revenue Market Share by Countries in 2019
Figure 71. Brazil Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Nilotinib Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Nilotinib Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Nilotinib Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Nilotinib Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Nilotinib Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Nilotinib Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Nilotinib Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Nilotinib Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Nilotinib Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Nilotinib Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Nilotinib Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Nilotinib Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…- 色素性絨毛結節性滑膜炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pigmented Villonodular Synovitis Drug Market The global Pigmented Villonodular Synovitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pigmented Villonodular Synovitis Drug S…
- タシグナの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tasigna market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tasigna market report provides a deta…
- 院内肺炎治療薬の世界市場（～2026年） Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus. Market An…
- 院内肺炎（HAP）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hospital-acquired Pneumonia (HAP) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…